Method for inhibiting stress-activated protein kinases
IL136028D0
Novel oral dosage form for carvedilol
CZ20001720A3
Novel oral dosage form for carvedilol
CZ20001310A3
Medicament for treating diseases caused by amyloid
ZA9809365B
Preparation for treating alzheimer's disease
NZ335080A
Use of dual non-selective beta-adrenoceptor and alpha1-adrenoceptor for inhibiting stress activated protein kinases(SAPK)
HU9903498A3
Use of dual non-selective beta-adrenoceptor and alfa-adrenoceptor antagonist for producing pharmaceutical compositions suitable for inhibiting stress-activated protein kinases
ZA9707565B
Method for inhibiting the expression of fas
HU0300170D0
Use of carbazole derivatives for producing pharmaceutical compositions suitable for the treatment of congestive heart failure
US5760069A
Method of treatment for decreasing mortality resulting from congestive heart failure
US5393772A
Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation
AU3916193A
Method of employing carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation
US5308862A
Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation
WO9420096A1
Method of employing carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation
